Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Lapaquistat Co-Administered With Statins in Subjects With Hypercholesterolemia
This study has been terminated.
( Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents )
Study NCT00532311   Information provided by Takeda Global Research & Development Center, Inc.
First Received: September 18, 2007   Last Updated: January 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypercholesterolemia
More general conditions related to this trial
Dyslipidemias
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Stable statin therapy
Additional drug interventions recognized in this trial
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pravastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Takeda Global Research &Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services